Filing Flows › Kymera Therapeutics (KYMR) › How it makes money
How Kymera Therapeutics (KYMR) makes money
Kymera Therapeutics (KYMR) made $65.0M of revenue in the second quarter 2026 (Q2 2026), +466% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $65.0M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $65.0M | +466% |
| Q1 2026 | $34.4M | +56% |
| Q4 2025 | $2.9M | -61% |
| Q3 2025 | $2.8M | -26% |
| Q2 2025 | $11.5M | -55% |
| Q1 2025 | $22.1M | +115% |
| Q4 2024 | $7.4M | -85% |
From Kymera Therapeutics' 10-Q filed Aug 5, 2026 (on EDGAR).
Questions
How does Kymera Therapeutics make money?
Kymera Therapeutics (KYMR) made $65.0M of revenue in the second quarter 2026 (Q2 2026), +466% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.